SCHEMBL5774366

SCHEMBL5774366

C=C(c1ccccn1)N1CCCC1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 3/20 0.55
L3MBTL1 Q9Y468 2/20 0.53
CES2 O00748 1/20 0.44
CES1 P23141 1/20 0.44
SMN1; SMN2 Q16637 2/20 0.43
MAPT P10636 2/20 0.43
NPC1 O15118 1/20 0.43
PKM P14618 1/20 0.43
HTT P42858 1/20 0.43
RAB9A P51151 1/20 0.43
KLF5 Q13887 1/20 0.43
LMNA P02545 3/20 0.42
NAPRT Q6XQN6 1/20 0.42
P4HTM Q9NXG6 1/20 0.42
ALDH1A1 P00352 3/20 0.41
KCNA5 P22460 3/20 0.41
KCNE1 P15382 1/20 0.41
CHRM1 P11229 1/20 0.40
ADRA2B P18089 1/20 0.40
SLC6A4 P31645 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23570343 0.84 L3MBTL1 (0.49) HSP90AA1L3MBTL1CES2CES1SMN1; SMN2
SCHEMBL26203601 0.80 L3MBTL1 (0.49) HSP90AA1L3MBTL1ALDH1A1CHRM1KCNH2
SCHEMBL19149496 0.78 L3MBTL1 (0.54) HSP90AA1L3MBTL1CES2CES1SMN1; SMN2
SCHEMBL19149494 0.78 CES2 (0.55) HSP90AA1L3MBTL1CES2CES1SMN1; SMN2
SCHEMBL18228118 0.78 L3MBTL1 (0.86) L3MBTL1CES2CES1SMN1; SMN2HTT
SCHEMBL3390298 0.78 L3MBTL1 (0.86) L3MBTL1CES2CES1SMN1; SMN2HTT
SCHEMBL743980 0.76 HSP90AA1 (0.57) HSP90AA1L3MBTL1CES2CES1SMN1; SMN2
SCHEMBL15364567 0.76 L3MBTL1 (0.47) HSP90AA1L3MBTL1CES2CES1SMN1; SMN2
SCHEMBL31305639 0.76 L3MBTL1 (0.83) L3MBTL1CES2CES1SMN1; SMN2MAPT
SCHEMBL969439 0.76 L3MBTL1 (0.83) L3MBTL1CES2CES1SMN1; SMN2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1054887-B1 BICYCLIC PYRIDINE AND PYRIMIDINE DERIVATIVES AS NEUROPEPTIDE Y RECEPTOR ANTAGONISTS AMGEN INC (US) 2006-04-12 EP disclosed
US-6583154-B1 Neuropeptide Y antagonist; pyrrolo-(3,2-b)pyridines and pyrrolo-(3,2-d)pyrimidines AMGEN INC. 2003-06-24 US disclosed
US-6187777-B1 PYRROLO(3,2-D)PYRIMIDINE DERIVATIVES; NEUROPEPTIDE Y AND CORTICOTROPIN RELEASING FACTOR MODULATORS; DIETETICS; ANTIDIABETIC, ANTIINFLAMMATORY, AND ANTITUMOR AGENTS AMGEN INC. 2001-02-13 US disclosed
EP-1054887-A1 BICYCLIC PYRIDINE AND PYRIMIDINE DERIVATIVES AS NEUROPEPTIDE Y RECEPTOR ANTAGONISTS Amgen Inc. (US) 2000-11-29 EP disclosed
WO-1999040091-A1 BICYCLIC PYRIDINE AND PYRIMIDINE DERIVATIVES AS NEUROPEPTIDE Y RECEPTOR ANTAGONISTS AMGEN INC. (US) 1999-08-12 WO disclosed